Regulatory T cells in immune surveillance and treatment of cancer

Seminars in Cancer Biology

Volumn 16, Issue 2, 2006, Pages 115-123

  Yamaguchi, Tomoyuki ^a   Sakaguchi, Shimon ^a,b  

^a KYOTO UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Regulatory T cells; Tumor immunity

Indexed keywords

CD4 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GLUCOCORTICOID; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 2 RECEPTOR ALPHA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR;

ANTINEOPLASTIC ACTIVITY; CANCER THERAPY; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOSURVEILLANCE; REGULATORY T LYMPHOCYTE; REVIEW; TUMOR CELL; TUMOR GROWTH; TUMOR IMMUNITY;

ANTIGENS, CD4; AUTOIMMUNITY; HUMANS; IMMUNOLOGIC SURVEILLANCE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; NEOPLASMS; RECEPTORS, INTERLEUKIN-2; T-LYMPHOCYTES, REGULATORY;

EID: 31644432589     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semcancer.2005.11.005     Document Type: Review

References (50)

1. G.P. Dunn, L.J. Old, and R.D. Schreiber The three Es of cancer immunoediting Annu Rev Immunol 22 2004 329 360
2. P. Van Der Bruggen, Y. Zhang, and P. Chaux Tumor-specific shared antigenic peptides recognized by human T cells Immunol Rev 188 2002 51 64
3. S. Sakaguchi Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses Annu Rev Immunol 22 2004 531 562
4. M. Asano, M. Toda, N. Sakaguchi, and S. Sakaguchi Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation J Exp Med 184 1996 387 396
5. M. Itoh, T. Takahashi, and N. Sakaguchi Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance J Immunol 162 1999 5317 5326
6. S. Hori, T. Nomura, and S. Sakaguchi Control of regulatory T cell development by the transcription factor Foxp3 Science 299 2003 1057 1061
7. J.D. Fontenot, M.A. Gavin, and A.Y. Rudensky Foxp3 programs the development and function of CD4+CD25+ regulatory T cells Nat Immunol 4 2003 330 336
8. R. Khattri, T. Cox, S.A. Yasayko, and F. Ramsdell An essential role for Scurfin in CD4+CD25+ T regulatory cells Nat Immunol 4 2003 337 342
9. S. Sakaguchi, N. Sakaguchi, M. Asano, M. Itoh, and M. Toda Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases J Immunol 155 1995 1151 1164
10. K.J. Maloy, F. Powrie, and Regulatory T cells in the control of immune pathology Nat Immunol 2 2001 816 822
11. T. Takahashi, Y. Kuniyasu, and M. Toda Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state Int Immunol 10 1998 1969 1980
12. M.S. Jordan, A. Boesteanu, and A.J. Reed Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide Nat Immunol 2 2001 301 306
13. C.S. Hsieh, Y. Liang, A.J. Tyznik, S.G. Self, D. Liggitt, and A.Y. Rudensky Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors Immunity 21 2004 267 277
14. A.M. Thornton, and E.M. Shevach CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production J Exp Med 188 1998 287 296
15. S. Sakaguchi Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self Nat Immunol 6 2005 345 352
16. V.L. Godfrey, J.E. Wilkinson, and L.B. Russell X-linked lymphoreticular disease in the scurfy (sf) mutant mouse Am J Pathol 138 1991 1379 1387
17. H.D. Ochs, S.F. Ziegler, and T.R. Torgerson FOXP3 acts as a rheostat of the immune response Immunol Rev 203 2005 156 164
18. K. Ko, S. Yamazaki, and K. Nakamura Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells J Exp Med 202 2005 885 891
19. T.J. Curiel, G. Coukos, and L. Zou Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival Nat Med 10 2004 942 949
20. T. Sasada, M. Kimura, Y. Yoshida, M. Kanai, and A. Takabayashi CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression Cancer 98 2003 1089 1099
21. R. Setoguchi, S. Hori, T. Takahashi, and S. Sakaguchi Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization J Exp Med 201 2005 723 735
22. T.R. Malek, and A.L. Bayer Tolerance, not immunity, crucially depends on IL-2 Nat Rev Immunol 4 2004 665 674
23. B. Salomon, and J.A. Bluestone Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation Annu Rev Immunol 19 2001 225 252
24. B. Salomon, D.J. Lenschow, and L. Rhee B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes Immunity 12 2000 431 440
25. T. Takahashi, T. Tagami, and S. Yamazaki Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4 J Exp Med 192 2000 303 310
26. S. Read, V. Malmstrom, and F. Powrie Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation J Exp Med 192 2000 295 302
27. Q. Tang, E.K. Boden, K.J. Henriksen, H. Bour-Jordan, M. Bi, and J.A. Bluestone Distinct roles of CTLA-4 and TGF-beta in CD4+CD25+ regulatory T cell function Eur J Immunol 34 2004 2996 3005
28. U. Grohmann, C. Orabona, and F. Fallarino CTLA-4-Ig regulates tryptophan catabolism in vivo Nat Immunol 3 2002 1097 1101
29. S. Paust, L. Lu, N. McCarty, and H. Cantor Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease Proc Natl Acad Sci USA 101 2004 10398 10403
30. C.A. Chambers, M.S. Kuhns, J.G. Egen, and J.P. Allison CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy Annu Rev Immunol 19 2001 565 594
31. J. Shimizu, S. Yamazaki, T. Takahashi, Y. Ishida, and S. Sakaguchi Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance Nat Immunol 3 2002 135 142
32. R.S. McHugh, M.J. Whitters, and C.A. Piccirillo CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor Immunity 16 2002 311 323
33. O. Annacker, O. Burlen-Defranoux, R. Pimenta-Araujo, A. Cumano, and A. Bandeira Regulatory CD4 T cells control the size of the peripheral activated/memory CD4 T cell compartment J Immunol 164 2000 3573 3580
34. G.L. Stephens, R.S. McHugh, and M.J. Whitters Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+CD25+ T cells J Immunol 173 2004 5008 5020
35. F. Kanamaru, P. Youngnak, and M. Hashiguchi Costimulation via glucocorticoid-induced TNF receptor in both conventional and CD25+ regulatory CD4+ T cells J Immunol 172 2004 7306 7314
36. G. Peng, Z. Guo, and Y. Kiniwa Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function Science 309 2005 1380 1384
37. I. Caramalho, T. Lopes-Carvalho, D. Ostler, S. Zelenay, M. Haury, and J. Demengeot Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide J Exp Med 197 2003 403 411
38. S. Yamazaki, T. Iyoda, and K. Tarbell Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells J Exp Med 198 2003 235 247
39. Z. Fehervari, and S. Sakaguchi Control of Foxp3+ CD25+CD4+ regulatory cell activation and function by dendritic cells Int Immunol 16 2004 1769 1780
40. J. Shimizu, S. Yamazaki, and S. Sakaguchi Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity J Immunol 163 1999 5211 5218
41. S. Onizuka, I. Tawara, J. Shimizu, S. Sakaguchi, T. Fujita, and E. Nakayama Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody Cancer Res 59 1999 3128 3133
42. P. Yu, Y. Lee, and W. Liu Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors J Exp Med 201 2005 779 791
43. M.J. Turk, J.A. Guevara-Patino, G.A. Rizzuto, M.E. Engelhorn, S. Sakaguchi, and A.N. Houghton Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells J Exp Med 200 2004 771 782
44. G.Q. Phan, J.C. Yang, and R.M. Sherry Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma Proc Natl Acad Sci USA 100 2003 8372 8377
45. S.A. Rosenberg, J.C. Yang, and N.P. Restifo Cancer immunotherapy: moving beyond current vaccines Nat Med 10 2004 909 915
46. N.A. Danke, D.M. Koelle, C. Yee, S. Beheray, and W.W. Kwok Autoreactive T cells in healthy individuals J Immunol 172 2004 5967 5972
47. L.S. Taams, M. Vukmanovic-Stejic, and J. Smith Antigen-specific T cell suppression by human CD4+CD25+ regulatory T cells Eur J Immunol 32 2002 1621 1630
48. K. Wing, S. Lindgren, and G. Kollberg CD4 T cell activation by myelin oligodendrocyte glycoprotein is suppressed by adult but not cord blood CD25+ T cells Eur J Immunol 33 2003 579 587
49. S. Sakaguchi, and N. Sakaguchi Role of genetic factors in organ-specific autoimmune diseases induced by manipulating the thymus or T cells, and not self-antigens Rev Immunogenet 2 2000 147 153
50. M. Awwad, and R.J. North Immunologically mediated regression of a murine lymphoma after treatment with anti-L3T4 antibody. A consequence of removing L3T4+ suppressor T cells from a host generating predominantly Lyt-2+ T cell-mediated immunity J Exp Med 168 1988 2193 2206